Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10901
Harvard Bioscience
HBIO
$30.3M
| $145K | ﹤0.01% |
6,872
-4,727
| -41% | -$109K |
|
10902
CALL
NerdWallet
NRDS
$629M
| $145K | ﹤0.01% |
10,900
-13,500
| -55% | -$180K |
|
10903
Procure Space ETF
UFO
$634M
| $145K | ﹤0.01% |
+6,240
| New | +$133K |
|
|
WIMI
10904
CALL
WiMi Hologram Cloud
WIMI
$25M
| $145K | ﹤0.01% |
7,830
+4,870
| +165% | +$46.6K |
|
10905
Hooker Furnishings Corp
HOFT
$158M
| $145K | ﹤0.01% |
+10,337
| New | +$174K |
|
10906
CALL
Pulse Biosciences
PLSE
$3.18B
| $145K | ﹤0.01% |
8,300
-3,600
| -30% | -$63.5K |
|
10907
Zura Bio
ZURA
$534M
| $144K | ﹤0.01% |
57,779
-279,049
| -83% | -$994K |
|
10908
CALL
Varex Imaging
VREX
$779M
| $144K | ﹤0.01% |
9,900
-11,300
| -53% | -$158K |
|
|
ORGN
10909
CALL
DELISTED
Origin Materials
ORGN
| $144K | ﹤0.01% |
3,760
-4,647
| -55% | -$176K |
|
10910
CALL
Quad
QUAD
$513M
| $144K | ﹤0.01% |
20,700
+1,900
| +10% | +$12.9K |
|
10911
PUT
AerSale
ASLE
$280M
| $144K | ﹤0.01% |
22,900
-70,600
| -76% | -$405K |
|
10912
CALL
ProShares UltraShort Real Estate
SRS
$15.6M
| $144K | ﹤0.01% |
2,775
+800
| +41% | +$38K |
|
|
FOCL
10913
EDAP TMS S.A.
FOCL
$178M
| $144K | ﹤0.01% |
65,242
+28,679
| +78% | +$71.9K |
|
10914
US Global Investors
GROW
$39.4M
| $144K | ﹤0.01% |
59,062
+11,009
| +23% | +$27K |
|
|
FIRY
10915
Firy Inc
FIRY
$156M
| $144K | ﹤0.01% |
+28,647
| New | +$153K |
|
|
KWY
10916
Kingsway Corp
KWY
$285M
| $144K | ﹤0.01% |
+17,213
| New | +$151K |
|
10917
Acacia Research
ACTG
$448M
| $144K | ﹤0.01% |
33,170
+20,814
| +168% | +$94.3K |
|
10918
PUT
Steris
STE
$22.7B
| $144K | ﹤0.01% |
700
| – | – |
|
10919
Tradr 2X Long Innovation ETF
TARK
$16.3M
| $144K | ﹤0.01% |
3,294
-2,706
| -45% | -$110K |
|
10920
CALL
Perspective Therapeutics
CATX
$365M
| $144K | ﹤0.01% |
45,000
+43,100
| +2,268% | +$352K |
|
|
ACCS
10921
ACCESS Newswire
ACCS
$19.2M
| $144K | ﹤0.01% |
+16,055
| New | +$159K |
|
10922
CALL
Rockwell Medical
RMTI
$29.2M
| $143K | ﹤0.01% |
7,030
+2,800
| +66% | +$81.7K |
|
10923
CALL
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11.9B
| $143K | ﹤0.01% |
4,000
-2,700
| -40% | -$101K |
|
|
NFGC
10924
PUT
New Found Gold
NFGC
$649M
| $143K | ﹤0.01% |
78,700
-500
| -0.6% | -$1.02K |
|
10925
Standard BioTools
LAB
$280M
| $143K | ﹤0.01% |
81,589
+15,919
| +24% | +$29.7K |
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,423 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.